EXCLUDER – Evaluation of the GORE EXCLUDER Iliac Branch Endoprosthesis for the Treatment of Common Iliac Artery Aneurysms or Aorto-Iliac Aneurysms. Primary Investigator: William Shutze, MD
Experience with Endovascular Aortic Repairs at BUMC. Primary Investigator: William Shutze, MD
Extended Release Exenatide vs. Placebo – A Prospective, double blind, placebo controlled, parallel group, randomized trial of extended release exenatide versus placebo in diabetic patients with type 4 cardiorenal syndrome. Primary Investigator: Peter A. McCullough, MD
Facilitating Patient Reported Outcome Measurement for Key Conditions. Primary Investigator: Peter McCullough, MD
GORE Hybrid Vascular Graft – Evaluation of antiplatelet factor 4 / heparin antibodies in hemodialysis patients implanted with the GORE Hybrid Vascular Graft versus non-heparin bonded synthetic vascular grafts. Primary Investigator: Stephen Hohmann, MD
GREAT – Global Registry for Endovascular Aortic Treatment. Primary Investigator: Dennis Gable, MD
Gross and histological features of mitral valve prolapse. Primary Investigator: William C. Roberts, MD
HeartWare ® Ventricular Assist System( VAS) – Prospective, randomized, controlled, un-blinded, multi-center clinical trial to evaluate the HeartWare ® Ventricular Assist System( VAS) for Destination Therapy of advanced heart failure. Primary Investigator: Gonzalo Gonzalez-Stawinski, MD
Heart Weight in Autopsy Cases. Primary Investigator: William C. Roberts, MD
HUMANITY – An Assessment of Humacyte’ s Human Acellular Vessel in Patients Needing Renal Replacement Therapy: A Comparison with ePTFE Grafts as Conduits for Hemodialysis. Primary Investigator: Stephen Hohmann, MD
Impact of Enhanced External Counterpulsation – EECP on Heart Failure Outcomes Following Hospitalization for Acutely Decompensated Heart Failure. Primary Investigator: Peter A. McCullough, MD
Impact of Troponin Testing Across the Baylor Scott and White NTX Region. Primary Investigator: Robert Kowal, MD
Low-Risk TAVR Patients – Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement. Primary Investigator: Robert Stoler, MD
Infrageniculate Peripheral Disease Prospective Trial – Comparing laser atherectomy to angioplasty with / without stenting for infrageniculate peripheral disease. Primary Investigator: William Shutze, MD
Instant noodle and cardiometabolic risk factors – Dietary pattern, instant noodle and cardiometabolic risk factors: Primary Investigators: Hyun Shin, MD, Peter A. McCullough, MD
ION Paclitaxel-Eluting Platinum Chrominum Coronary Stent System – A U. S. post-approval study. Primary Investigator: Robert Stoler, MD
IXCELL EXTENSION – A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Tolerability of Transendocardial Injection of Ixmyelocel-T in Subjects with Heart Failure Due to Ischemia Dilated Cardiomyopathy( IDCM). Primary Investigator: Cara East, MD
JOSTENT – Coronary Stent Graft Humanitarian Use Device. Primary Investigator: Robert Stoler, MD
Levo CTS – A double-blind, randomized placebocontrolled study of Levosimendan in Patients with Left Ventricular Systolic Dysfunction undergoing cardiac surgery requiring cardiopulmonary bypass; LEVO- CTS. Primary Investigators: Daniel Gunn, MD, Cara East, MD
Lixisenatide in Type 2 Diabetes – A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate cardiovascular outcomes during treatment with lixisenatide in type 2 diabetes patients after an acute coronary syndrome event. Primary Investigator: Cara East, MD
LOWER – Lomitapide Observational Worldwide Evaluation Registry. Primary Investigator: Peter A. McCullough, MD
LVAD and Medical Management in Ambulatory HF Patients – Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients. Primary Investigator: Shelley Hall, MD
Measurement of Functional Capacity Requirements of Farmers: Implications for a Cardiac Rehabilitation Training Program. Primary Investigator: Jenny Adams, PhD
Medtronic CoreValve – Continued Access Study( Extreme Risk Patients) – Evolut R, Expanded Use, U. S. Pivotal Trial. Primary Investigator: Robert Stoler, MD
Medtronic Endeavor ® Resolute Zotarolimus Eluting Coronary Stent System – A clinical evaluation of the Medtronic Endeavor ® Resolute Zotarolimus Eluting Coronary Stent System in the treatment of De Novo lesions in native coronary arteries with a reference vessel diameter of 2.25mm to 4.2mm. Primary Investigator: Robert Stoler, MD
Mental Health of Brief-Stay Cardiac Patients – Assessment of the value of a brief intervention and referral to a mental health professional for brief-stay cardiac hospital patients who report feelings of hopelessness and worthlessness. Primary Investigator: Michael Davis, ThM
Micra Transcatheter Pacing System Continued Access Protocol. Primary Investigator: Robert Kowal, MD
Mitral and Aortic Valve Replacement Indications and Results – Indications for and results of combined mitral and aortic valve replacement at BUMC. Primary Investigator: William C. Roberts, MD
Mitral Annular Calcium – Mitral valve replacement because of mitral stenosis due to massive mitral annular calcium. Primary Investigator: William C. Roberts, MD
Mitral Valve Replacement After Failed Mitral Repair – Replacement with ring insertion for pure mitral regurgitation. Primary Investigator: William C. Roberts, MD
Neurocognitive function in destination therapy patients before and after receiving a continuous flow left ventricular assist device. Primary Investigators: Sandra Carey, NP, Shelley Hall, MD
ODYSSEY OLE – Open-Label Extension Study of EFC12492, R727-CL-1112, EFC12732, & LTS11717 Studies to Assess the Long-Term Safety and Efficacy of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia. Primary Investigator: Cara East, MD
ODYSSEY OUTCOMES – Randomized, Double- Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553 / REGN727 on the Occurence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome. Primary Investigator: Cara East, MD
Pain Relief Associated with Interpleural Tubes – Evaluation of a New Method of Relieving Pain Associated with Interpleural Tubes following Thoracic or Cardiac Surgery. Primary Investigator: Robert F. Hebeler, Jr., MD
PLATINUM – A prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System( PROMUS Element™) for the Treatment of up to two De Novo Coronary Artery Lesions. Primary Investigator: Robert Stoler, MD
Post-MI Remodeling Prevention Therapy Study. Primary Investigator: Jay Franklin, MD
Pragmatic Trial of Airway Management in Outof-Hospital Cardiac Arrest( Pragmatic Airway Resuscitation Trial). Primary Investigator: John Garrett, MD
Prasugrel use in patients receiving bivalirudin in the cardiac cath lab. Primary Investigator: Jeffrey M. Schussler, MD
Preventive Cardiology Registry. Primary Investigator: Peter A. McCullough, MD
PROACT Trial – Clinical trial of the On-X ® Valve using low-dose anticoagulation, or by its informal designation prospective randomized On-X ® Valve Anticoagulation Clinical Trial( PROACT). Primary Investigator: Baron L. Hamman, MD
Protocol to conduct a broad range of retrospective data reviews on heart transplants, lung transplants, VAD and cardiology. Primary Investigator: Gonzalo Gonzalez-Stawinski, MD
Pulmonary Vein Reconnection – Pulmonary vein reconnection after cryoballoon pulmonary vein isolation. Primary Investigator: Kevin Wheelan, MD
Pure Aortic Regurgitation – Associated with congenitally malformed bicuspid aortic valve and unassociated with infective endocarditis. Primary Investigator: William C. Roberts, MD
QUARK – A randomized, double-blind, placebo controlled, Phase II study to evaluate efficacy and safety of QPI-1002 for the prevention of acute kidney injury in subjects at high risk for AKI following cardiac surgery. Primary Investigator: Robert F. Hebeler, Jr., MD
Radial Versus Femoral Artery Approach – Clinical outcomes and metabolomic and damage associated molecular patterns of acute kidney injury in patients undergoing percutaneous coronary intervention via the radial versus femoral artery approach. Primary Investigator: Jeffrey M. Schussler, MD
OUTCOMES 2016
69